Blood pressure-independent effects in rats with human renin and angiotensinogen genes. 2000

E Mervaala, and D N Müller, and F Schmidt, and J K Park, and V Gross, and M Bader, and V Breu, and D Ganten, and H Haller, and F C Luft
Franz Volhard Clinic, Medical Faculty of the Charité, Humboldt University of Berlin, Germany.

The blood pressure-independent effects of angiotensin II (Ang II) were examined in double transgenic rats (dTGR) harboring human renin and human angiotensinogen genes, in which the end-organ damage is due to the human components of the renin angiotensin system. Triple-drug therapy (hydralazine 80 mg/L, reserpine 5 mg/L, and hydrochlorothiazide 25 mg/L in drinking water) was started immediately after weaning. Triple-drug therapy normalized blood pressure and coronary resistance, only partially prevented cardiac hypertrophy, and had no effect on ratio of renal weight to body weight. Although triple-drug therapy delayed the onset of renal damage, severe albuminuria nevertheless occurred. Semiquantitative scoring of ED-1-positive and MIB-5-positive (nuclear cell proliferation-associated antigen Ki-67) cells showed profound perivascular monocyte/macrophage infiltration and cell proliferation in kidneys and hearts of untreated dTGR. Triple-drug therapy had only a minimal effect on local inflammatory response or vascular cell proliferation. In contrast, a novel orally active human renin inhibitor (HRI), 30 mg/kg by gavage for 4 weeks, normalized blood pressure and coronary resistance and also prevented cardiac hypertrophy and albuminuria. ED-1-positive cells and MIB-5-positive cells were decreased by HRI in hearts and kidneys almost to levels observed in normotensive Sprague-Dawley rats. The renoprotective effects of HRI were at least in part due to improved renal hemodynamics and distal tubular function, since HRI shifted renal pressure-diuresis/natriuresis curves leftward by approximately 35 mm Hg, increased glomerular filtration rate and renal blood flow, and shifted the fractional water and sodium excretion curves leftward. In untreated dTGR, plasma Ang II was increased by 400% and renal Ang II level was increased by 300% compared with Sprague-Dawley rats. HRI decreased plasma human renin activity by 95% and normalized Ang II levels in both plasma and kidney compared with triple-drug therapy. Our findings indicate that in dTGR harboring human renin and angiotensinogen genes, Ang II causes end-organ damage and promotes inflammatory response and cellular growth largely independent of blood pressure.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D009318 Natriuresis Sodium excretion by URINATION. Natriureses
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D012079 Renal Circulation The circulation of the BLOOD through the vessels of the KIDNEY. Kidney Circulation,Renal Blood Flow,Circulation, Kidney,Circulation, Renal,Blood Flow, Renal,Flow, Renal Blood
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D012110 Reserpine An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use. Raunervil,Raupasil,Rausedil,Rausedyl,Serpasil,Serpivite,V-Serp,V Serp
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004231 Diuresis An increase in the excretion of URINE. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Diureses

Related Publications

E Mervaala, and D N Müller, and F Schmidt, and J K Park, and V Gross, and M Bader, and V Breu, and D Ganten, and H Haller, and F C Luft
January 2005, Kidney & blood pressure research,
E Mervaala, and D N Müller, and F Schmidt, and J K Park, and V Gross, and M Bader, and V Breu, and D Ganten, and H Haller, and F C Luft
December 1998, Journal of the American Society of Nephrology : JASN,
E Mervaala, and D N Müller, and F Schmidt, and J K Park, and V Gross, and M Bader, and V Breu, and D Ganten, and H Haller, and F C Luft
November 2010, PloS one,
E Mervaala, and D N Müller, and F Schmidt, and J K Park, and V Gross, and M Bader, and V Breu, and D Ganten, and H Haller, and F C Luft
June 1993, The Journal of biological chemistry,
E Mervaala, and D N Müller, and F Schmidt, and J K Park, and V Gross, and M Bader, and V Breu, and D Ganten, and H Haller, and F C Luft
January 1991, Biomedica biochimica acta,
E Mervaala, and D N Müller, and F Schmidt, and J K Park, and V Gross, and M Bader, and V Breu, and D Ganten, and H Haller, and F C Luft
January 1999, Hypertension (Dallas, Tex. : 1979),
E Mervaala, and D N Müller, and F Schmidt, and J K Park, and V Gross, and M Bader, and V Breu, and D Ganten, and H Haller, and F C Luft
August 1992, Proceedings of the National Academy of Sciences of the United States of America,
E Mervaala, and D N Müller, and F Schmidt, and J K Park, and V Gross, and M Bader, and V Breu, and D Ganten, and H Haller, and F C Luft
April 1997, Hypertension (Dallas, Tex. : 1979),
E Mervaala, and D N Müller, and F Schmidt, and J K Park, and V Gross, and M Bader, and V Breu, and D Ganten, and H Haller, and F C Luft
August 2012, Journal of hypertension,
E Mervaala, and D N Müller, and F Schmidt, and J K Park, and V Gross, and M Bader, and V Breu, and D Ganten, and H Haller, and F C Luft
January 1999, Blood pressure,
Copied contents to your clipboard!